It’s shaping up to be another big year for Canopy Growth (TSX:WEED)(NYSE:CGC). After getting off to a great start in early 2019, the company continued its expansion, acquiring Spanish producer Cafina and pursuing a licence to sell pot in New York State. As a result of its rapid growth, Canopy is set to become the first weed stock on the S&P/TSX…
Read More
I have long written about the problem with cannabis stocks and their valuations and the expectations that are built into them. I’ve also written about the strong likelihood that higher-than-expected spending, shareholder dilution, and slower-than-expected revenue growth will likely be very detrimental to stock prices. The industry, cycle, and growth are in their early stages. Aphria (TSX:APHA)(NYSE:APHA) reported its third-quarter…
Read More
For investors looking to score cheap stocks with a lot of upside, targeting shares that are trading below $5 is an easy way to do so. Below are three stocks that fit that criteria and that could be great buys today. Green Organic Dutchman Holdings (TSX:TGOD) has been struggling over the past month, as it has lost more than 10%…
Read More
MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MEDIF) is a global leader in the cannabis extraction space. The company focuses on specialized and research-driven extraction, distillation, purification, and isolation. The cannabis extraction company’s Canadian-listed shares are gaining 10%, through afternoon trading on Tuesday, April 16, 2019. Over the past three months, MediPharm Labs has seen average daily volume of 858,047 shares.…
Read More
Aphria (TSX:APHA)(NYSE:APHA) released its third-quarter results on Monday. The company’s revenues were up more than 600% in what was its first quarter with a full three months of recreational sales. However, with Aphria recording a loss of more than $108 million, investors were left unimpressed, as the stock dropped 14% on the day the results were announced. It was a…
Read More
The hype for marijuana stocks has been strong in recent years. However, not everyone is sold on their ability to meet the expectations that Wall Street has set for them. With a lot of hurdles present in the cannabis industry and many hiccups since legalization, it hasn’t been smooth sailing. Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has been no exception to that…
Read More
Cannabis investors have been paying some big premiums in recent years to own stocks that offered little in the way of earnings and just relied on promises of future growth. However, now that we’ve seen marijuana companies start to report some strong sales numbers, those valuations might not be as astronomical as they once were. Let’s take a look at…
Read More
Cannabis stocks have been going gangbusters for nearly a year. In many cases, small, unknown companies have been catapulted into the spotlight, minting thousands of millionaires in as little as a few weeks. In 2015, shares of Canopy Growth (TSX:WEED)(NYSE:CGC) were under $2 apiece. This week, the stock closed above $55 per share. That meteoric rise has made Canopy one…
Read More
Cannabis stocks such as Hexo (TSX:HEXO) have seen some substantial gains over the past few years. Apart from the lucrative run-up towards legalization, Hexo and others have been spending like mad to increase their production capabilities, branch out to new markets, and establish complementary product streams that will be exposed to the market over the next few years. Despite being…
Read More
Canada’s booming marijuana industry has been attracting considerable attention, especially since it became the first developed nation to legalize the recreational use of the drug. That event triggered a massive boom among marijuana companies with Canopy Growth (TSX:WEED)(NYSE:CGC) emerging as the industry leader. The marijuana cultivator has grown from being the first publicly traded marijuana company in North America in…
Read More